Golden State Equity Partners Has $681,000 Holdings in Colgate-Palmolive (NYSE:CL)

Golden State Equity Partners boosted its holdings in shares of Colgate-Palmolive (NYSE:CL) by 56.2% in the fourth quarter, HoldingsChannel reports. The fund owned 7,491 shares of the company’s stock after buying an additional 2,696 shares during the quarter. Golden State Equity Partners’ holdings in Colgate-Palmolive were worth $681,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive during the 4th quarter worth about $32,000. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter worth about $42,000. Capital Performance Advisors LLP acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at about $53,000. Synergy Asset Management LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter valued at about $49,000. Finally, Prospera Private Wealth LLC acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at about $64,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on CL shares. TD Cowen reduced their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Barclays reduced their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Finally, Wells Fargo & Company reduced their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $102.00.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $86.64 on Monday. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The business’s 50 day moving average is $91.35 and its two-hundred day moving average is $97.17. The company has a market cap of $70.78 billion, a P/E ratio of 24.82, a P/E/G ratio of 3.70 and a beta of 0.44. Colgate-Palmolive has a 12 month low of $82.68 and a 12 month high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 405.81% and a net margin of 14.27%. During the same period in the prior year, the company posted $0.87 EPS. On average, equities analysts expect that Colgate-Palmolive will post 3.58 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.31%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.